Dopamine Transmission Imbalance in Neuroinflammation: Perspectives on Long-Term COVID-19
International Journal of Molecular Sciences · 15.03.2023 · 24 (6) · 5618
DOI: 10.3390/ijms24065618 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 15.03.2023. Verfasst von Maria Mancini und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Brain and Behavioral Sciences, University of Pavia, 27100 Pavia, Italy. Hauptthemen laut MEDLINE: COVID-19, Parkinson Disease. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 223 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondazione Regionale per la Ricerca Biomedica, Regione Lombardia, Fondazione Regionale per la Ricerca Biomedica (FRRB, Regione Lombardia).
Abstract (Originalsprache)
Dopamine (DA) is a key neurotransmitter in the basal ganglia, implicated in the control of movement and motivation. Alteration of DA levels is central in Parkinson’s disease (PD), a common neurodegenerative disorder characterized by motor and non-motor manifestations and deposition of alpha-synuclein (α-syn) aggregates. Previous studies have hypothesized a link between PD and viral infections. Indeed, different cases of parkinsonism have been reported following COVID-19. However, whether SARS-CoV-2 may trigger a neurodegenerative process is still a matter of debate. Interestingly, evidence of brain inflammation has been described in postmortem samples of patients infected by SARS-CoV-2, which suggests immune-mediated mechanisms triggering the neurological sequelae. In this review, we discuss the role of proinflammatory molecules such as cytokines, chemokines, and oxygen reactive species in modulating DA homeostasis. Moreover, we review the existing literature on the possible mechanistic interplay between SARS-CoV-2-mediated neuroinflammation and nigrostriatal DAergic impairment, and the cross-talk with aberrant α-syn metabolism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Brain and Behavioral Sciences, University of Pavia, 27100 Pavia, Italy.
- IRCCS Mondino Foundation, 27100 Pavia, Italy.
- Department of Clinical Science and Translational Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
- IRCCS Maugeri Pavia, 27100 Pavia, Italy.
- Department of Pharmacological and Biomolecular Sciences "Rodolfo Paoletti", University of Milan, 20133 Milan, Italy.
ORCID-Profile: Maria Mancini, Silvia Natoli, Fabrizio Gardoni, Antonio Pisani
Förderung
- Fondazione Regionale per la Ricerca Biomedica, Regione Lombardia
- Fondazione Regionale per la Ricerca Biomedica (FRRB, Regione Lombardia)
Zitieren
APA
Mancini, M., Natoli, S., Gardoni, F., Di Luca, M., & Pisani, A. (2023). Dopamine Transmission Imbalance in Neuroinflammation: Perspectives on Long-Term COVID-19. International Journal of Molecular Sciences, 24(6), 5618. https://doi.org/10.3390/ijms24065618
Vancouver
Mancini M, Natoli S, Gardoni F, Di Luca M, Pisani A. Dopamine Transmission Imbalance in Neuroinflammation: Perspectives on Long-Term COVID-19. International Journal of Molecular Sciences. 2023;24(6):5618. doi:10.3390/ijms24065618
BibTeX
@article{Mancini2023,
author = {Mancini, Maria and Natoli, Silvia and Gardoni, Fabrizio and Di Luca, Monica and Pisani, Antonio},
title = {Dopamine Transmission Imbalance in Neuroinflammation: Perspectives on Long-Term COVID-19},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {6},
pages = {5618},
doi = {10.3390/ijms24065618}
}
EUVIMED